ARTICLE | Company News
Shire declines MAb option from Cytovax
December 5, 2001 8:00 AM UTC
Cytovax (TSE:CXB) said partner Shire (LSE:SHP; SHPGY) will not exercise an option under the companies' June 2000 agreement to license a monoclonal antibody for Pseudomonas aeruginosa (see BioCentury,...